These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23288633)

  • 61. [New insights into molecular target therapy for colorectal cancer].
    Kanemitsu K; Yamashita K; Sumi Y; Suzuki S; Tanaka K; Kakeji Y
    Nihon Shokakibyo Gakkai Zasshi; 2012 Dec; 109(12):2021-30. PubMed ID: 23221050
    [No Abstract]   [Full Text] [Related]  

  • 62. Current status and problems of molecular target therapy for colorectal cancer.
    Tsuda T; Nakajima T; Boku N
    Nihon Shokakibyo Gakkai Zasshi; 2011 Jan; 108(1):19-23. PubMed ID: 21212591
    [No Abstract]   [Full Text] [Related]  

  • 63. Which strategies will lead to progress in the management of colorectal cancer?
    Goldberg RM
    Gastrointest Cancer Res; 2007; 1(4 Suppl 2):S33-6. PubMed ID: 19360145
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs.
    Layton JL; Lewis B; Ryan C; Beer TM; Sartor O
    Oncologist; 2019 Mar; 24(3):291-292. PubMed ID: 30568023
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Histochemical studies on cancer tissues. IV. Effects of antineoplastics on cancer tissues].
    AOKI T; MOCHIZUKI N; HANABUSA A; HASHIMOTO Y; IGARASHI K; NAKAGAWA H
    Gan; 1955 Sep; 46(2-3):447-9. PubMed ID: 13262450
    [No Abstract]   [Full Text] [Related]  

  • 66. Management guidelines for preventing exposure to antineoplastics.
    Liu W; Wu Z; Sun T; Liang S; Zhu J; Zhai S; Therapeutic Drug Monitoring Of Chinese Pharmacological Society DO; Professional Committee Of Chinese Pharmaceutical Association HP; Society Of Chinese Medical Association O; Branch Of China International Exchange And Promotive Association For Medical And Healthcare N; Of Drug-Induced Diseases Of Chinese Pharmacology Society D
    Chin J Cancer Res; 2023 Feb; 35(1):1-10. PubMed ID: 36910857
    [No Abstract]   [Full Text] [Related]  

  • 67. The study of a novel sorafenib derivative HLC-080 as an antitumor agent.
    Tang K; Luo C; Li Y; Lu C; Zhou W; Huang H; Chen X
    PLoS One; 2014; 9(7):e101889. PubMed ID: 25004130
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-angiogenic therapies for metastatic colorectal cancer: current and future perspectives.
    Marques I; Araújo A; de Mello RA
    World J Gastroenterol; 2013 Nov; 19(44):7955-71. PubMed ID: 24307789
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Off-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancer.
    Al-Marrawi MY; Saroya BS; Brennan MC; Yang Z; Dykes TM; El-Deiry WS
    Cancer Biol Ther; 2013 Aug; 14(8):703-10. PubMed ID: 23792568
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Translation initiation in colorectal cancer.
    Parsyan A; Hernández G; Meterissian S
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):387-95. PubMed ID: 22418835
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel antineoplastics targeting genetic changes in colorectal cancer.
    Joudeh J; Allen JE; Das A; Prabhu V; Farbaniec M; Adler J; El-Deiry WS
    Adv Exp Med Biol; 2013; 779():1-34. PubMed ID: 23288633
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges.
    Rogers JE; Dasari A; Eng C
    Oncologist; 2016 May; 21(5):563-70. PubMed ID: 27000464
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of novel targeted agents in the treatment of metastatic colorectal cancer.
    Berge E; Thompson C; Messersmith W
    Clin Colorectal Cancer; 2011 Dec; 10(4):266-78. PubMed ID: 21903484
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting NF-kappaB for colorectal cancer.
    Sakamoto K; Maeda S
    Expert Opin Ther Targets; 2010 Jun; 14(6):593-601. PubMed ID: 20367537
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.